Searchable abstracts of presentations at key conferences in endocrinology

ea0009oc29 | Oral Communication 4: Steroids | BES2005

Characterisation of a novel protein interacting with the glucocorticoid receptor

Rice L , Waters C , Garside H , White A , Ray D

Glucocorticoids (Gcs) exert their pleiotropic effects through activation of the ubiquitously expressed glucocorticoid receptor (GR). The mechanism of transcriptional activation by the GR involves interaction with co-modulator proteins. Glucocorticoid sensitivity is mediated by the expression level of these co-modulator proteins and GR concentration. Therefore, the aim of this study was to identify additional GR interacting proteins that may influence glucocorticoid sensitivity...

ea0005s6 | Androgens and Prostate Cancer | BES2003

Androgen action in the prostate

White H , Gamble S , Odontiadis M , Bevan C

Prostate growth during development and at puberty is dependent on androgens. After puberty, growth ceases and the secretory function of the organ is maintained in the presence of high circulating testosterone levels. However, in cases of benign prostatic hyperplasia and prostate cancer, growth resumes inappropriately. Like normal prostate growth, tumour growth is initially androgen-dependent; hence, treatment involves removing circulating androgens by chemical castration and o...

ea0009p65 | Growth and development | BES2005

Effect of active and treated acromegaly on PTH concentration, PTH target-organ sensitivity and phosphocalcium metabolism

White H , Ahmad A , Durham B , Joseph F , Fraser W , Vora J

PTH plays an important role in bone metabolism. Active acromegaly is associated with increased bone turnover. Reduction in bone turnover markers occurs following biochemical cure/control of acromegaly. We examined the effect of active acromegaly and its treatment on PTH concentration and PTH target-organ sensitivity.10 patients with active acromegaly (defined as GH nadir greater than 1mU/L following 75g oral glucose load and IGF1 above reference range) a...

ea0009p68 | Growth and development | BES2005

Effect of phosphate supplementation on PTH target-organ sensitivity during growth hormone replacement in adult growth hormone deficiency

White H , Ahmad A , Durham B , Joseph F , Fraser W , Vora J

Adult Growth Hormone Deficiency (AGHD) is associated with relative phosphate deficiency. Phosphate is an important determinant of serum PTH concentration. PTH target-organ sensitivity is reduced in AGHD and may underlie the pathogenesis of AGHD-related osteopaenia. We examined the effect of phosphate supplementation on change in PTH target-organ sensitivity when given simultaneously with Growth Hormone Replacement (GHR) in AGHD patients.24 AGHD patients ...

ea0009p109 | Endocrine tumours and neoplasia | BES2005

Leptin and the diurnal rhythm of blood pressure

Joseph F , Ul-Haq M , Ahmad A , Whittingham P , White H , Wallace A , Fraser W , Vora J

Background: Untreated adult growth hormone deficiency (AGHD) is associated with hypertension, obesity and hyperleptinemia. Leptin is linked to obesity related hypertension, is secreted in a circadian rhythm and may contribute to the regulation of BP circadian rhythmicity.Methods: We studied the relationship between plasma leptin (half hourly samples), ambulatory systolic BP (SBP), diastolic BP (DBP) and mean arterial pressure (MAP) over a 24-h period in ...

ea0009p133 | Steroids | BES2005

Modulation of glucocorticoid sensitivity by retroviral gene transfer

Le Rouzic P , Gillingham H , Berry A , Garside H , White A , Ray D

Glucocorticoid sensitivity is dependent on the intracellular concentration of the glucocorticoid receptor (GR). GR expression is regulated in a complex, cell-type specific manner, but in most cell types the GR is subject to negative autoregulation by glucocorticoid exposure. Many human diseases are associated with reduced tissue sensitivity to glucocorticoids, including inflammatory arthritis, asthma, and chronic obstructive pulmonary disease. Therefore there is interest in ap...

ea0007p2 | Bone | BES2004

Does leptin regulate bone turnover in adult growth hormone deficiency?

Joseph F , Ahmad A , Wallace A , White H , Durham B , Fraser W , Vora J

Leptin stimulates osteoblastic cell proliferation, differentiation and mineralisation and inhibits osteoclast generation; leptin secretion and bone turnover are altered in adult growth hormone deficiency, a condition associated with osteoporosis. The aim of this study was to investigate leptin circadian rhythm and its association with bone turnover in untreated AGHD and following growth hormone replacement (GHR).We sampled peripheral venous blood at half...

ea0007p5 | Bone | BES2004

Growth hormone replacement is important for the restoration of PTH circadian rhythmicity in older adult growth hormone deficient patients

White H , Ahmad A , Joseph F , Prabhakar V , Patwala A , Whittingham P , Durham B , Fraser W , Vora J

Adult Growth Hormone Deficiency (AGHD) is associated with osteoporosis. PTH circadian rhythmicity is important for bone remodelling. Abnormalities in PTH circadian rhythms, including a blunted nocturnal rise, have been reported in AGHD and may contribute to osteoporosis development. GH replacement (GHR) results in improvement of PTH circadian rhythmicity and bone mineral density (BMD). In health, increasing age is associated with declining GH secretion and the appropriateness ...

ea0007p6 | Bone | BES2004

Parathyroid hormone and phosphate circadian rhythms are altered in osteopaenic adult growth hormone deficient patients

White H , Ahmad A , Joseph F , Chandran S , Corlett P , Durham B , Fraser W , Vora J

Alterations in PTH circadian rhythmicity have previously been reported in Adult Growth Hormone Deficiency (AGHD) and may contribute to the pathogenesis of AGHD-related osteoporosis. However, changes in PTH circadian rhythm have not been correlated with bone mineral density (BMD) in AGHD. Serum phosphate is a likely determinant of PTH rhythm. We examined the PTH and phosphate circadian rhythms in AGHD patients with reduced (defined as femoral neck T-score <-1.0) and normal B...